Health Secretary Patricia Hewitt announced last week (8 December) the creation of eleven Biomedical Research Centres (BRC) and awarded BRC status to the two hospitals in partnership with Imperial College. BRCs will be leaders in translating scientific research into benefits for patients. Imperial’s academic clinicians will work with their NHS colleagues to take research from the bench to the bedside, enabling the adoption of new technologies, techniques and treatments.
The award guarantees the partners research funding of £19.5 million per annum for the next five years, and makes the West London BRC the leading centre for the UK.
Trust Chief Executives Derek Smith and Julian Nettel, and Rector of Imperial College London Sir Richard Sykes said, “We are delighted to be recognised for the innovative research which is carried out through our partnership to advance healthcare and medical research around the world. Our research is at the forefront of biomedical invention with the primary goal of improving patient care.”
Awarding BRC status to the Trusts in academic partnership with Imperial is an endorsement of their intention to become the UK's first Academic Health Science Centre. (AHSC). The AHSC will be a healthcare organisation that integrates governance and management for service delivery, teaching and research, based on tried and tested models around the world. This concept represents a future that has captured the imagination and support of clinical leaders and senior management of all organisations and will enable West London to compete on a global stage.
The AHSC will be a magnet for investment and for clinical leaders who champion the creation and delivery of new diagnostic and treatment options to improve the lives and welfare of patients.
Staff, patients and local communities will be involved in designing and planning the AHSC as well as being formally consulted about it in 2007.
Between them the hospitals can already boast the best breast cancer survival rates; the best lung cancer survival rates; and the third and fourth fewest deaths during coronary artery by-pass operations. They have achieved this record by employing the very latest thinking, technology and treatments.
Imperial College is the UK’s leading clinical academic university with 140 clinical academic fellows and 53 clinical lecturers. It recently had its world-class reputation confirmed by the Times Higher Educational 2006 World University Rankings, which placed the university fourth in the world for biomedicine and ninth in the world overall.
Further endorsement was received in the Chancellor’s pre-budget statement this week (6 December). Gordon Brown announced that the government accepted the findings of a new report into UK Health Research funding, which included a statement of support for the AHSC model. The Cooksey report states: "Universities and Trusts might follow the US Academic Medical Centre model, as Imperial College and St. Mary's and Hammersmith NHS Trusts are doing with their plan to create the UK's first Academic Health Sciences Centre. This proposal, which promises to deliver greater integration of not only research strategies, but vital underpinning human resources and capital assets, should make for a more effective approach to health research and patient care at these institutions.”
Abigail Smith | alfa
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences